News & Updates

Show Multimedia Only
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024

Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.

Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024
Pneumococcal colonization rate lower in children with persistent asthma
Pneumococcal colonization rate lower in children with persistent asthma
05 Nov 2024 byStephen Padilla

Children with persistent asthma are less likely to be colonized with S. pneumoniae than those without asthma when seeking care for respiratory symptoms, reports a study.

Pneumococcal colonization rate lower in children with persistent asthma
05 Nov 2024
Obesity, prediabetes up risk of diabetes in statin-treated PWH
Obesity, prediabetes up risk of diabetes in statin-treated PWH
29 Oct 2024

People living with HIV (PWH) on statin therapy who have certain metabolic risk factors, such as obesity and prediabetes, are at greater risk of developing diabetes mellitus (DM), reports a study. This association is also present in those treated with placebo.

Obesity, prediabetes up risk of diabetes in statin-treated PWH
29 Oct 2024